Serina Therapeutics, Inc.

Serina Therapeutics, Inc. (ticker: SER) is an NYSE-listed pharmaceutical preparations company. DredgeCap's structured extraction of SER's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. SER reported $130K in revenue and -$6.90M for the period ending 2025-12-31, with operating cash flow of -$4.57M. Cash and equivalents stood at $24.53M (up 474.8% year-over-year). Total assets of $27.30M exceed total liabilities of $9.67M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.